PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
189 hedge funds and large institutions have $3.37B invested in PRA Health Sciences, Inc. in 2016 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 84 increasing their positions, 58 reducing their positions, and 19 closing their positions.
89% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 19
45% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 58
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 173 → 189 (+16)
3% less capital invested
Capital invested by funds: $3.48B → $3.37B (-$111M)
67% less call options, than puts
Call options by funds: $430K | Put options by funds: $1.31M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.4M |
| 2 |
Millennium Management
New York
|
+$38.6M |
| 3 |
Morgan Stanley
New York
|
+$37.3M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$35.2M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$32.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$412M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.7M |
| 3 |
HM
HealthCor Management
New York
|
-$20.6M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.4M |
| 5 |
Asset Management One
Tokyo,
Japan
|
-$8.15M |
PRAH Hedge Fund Activity: Q4 2016 in Review
189 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2016, worth a combined $3.37B — down 3.2% from $3.48B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PRAH positions and 19 closed out — a net gain of 17 holders — while 84 added to existing stakes and 58 trimmed.
The largest buyer was Vanguard Group, adding an estimated $46.4M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $412M.
- 189 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2016, up from 173 in Q3 2016.
- Funds reported $3.37B of PRA Health Sciences, Inc. stock for Q4 2016, down 3.2% quarter-over-quarter.
- 36 funds opened new PRA Health Sciences, Inc. positions in Q4 2016 and 19 closed out, a net change of +17 holders.
- The largest PRA Health Sciences, Inc. buyer in Q4 2016 was Vanguard Group, an estimated $46.4M added.
- The largest PRA Health Sciences, Inc. seller in Q4 2016 was Kohlberg Kravis Roberts & Co, an estimated $412M sold.
Based on aggregated 13F filings for Q4 2016.